Excelsior Biopharma Net Tangible Assets

Excelsior Biopharma (6496.TWO) currently reports a net tangible assets of $690M as of June 2026. That compares with $900M in the prior-year period — down 23.2% year over year. Use the charts on this page to explore Excelsior Biopharma's net tangible assets history and peer comparisons.

Excelsior Biopharma's net tangible assets decreased from $900M to $690M — a 23.2% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Excelsior Biopharma reported $690M in net tangible assets as of June 2026. That compares with $900M in the prior-year period — down 23.2% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current net tangible assets of $690M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Excelsior Biopharma, and consider following 6496.TWO for alerts when major investors trade the stock.